![Hans Tanner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hans Tanner
Directeur/Membre du Conseil chez
PAION AG
Profil
Hans Christoph Tanner is the founder of A&A Active Investor AG, 20 Minuten-Holding AG, 20 Minuten AG.
Currently, the roles include Director at Cosmo Holding SpA since 2005, Director at Cosmo Bioscience, Inc., Director at Qvanteq AG since 2010, Director at FARa Holz AG, Director at Wyss Zurich, Director at Lifematrix Technologies AG, Member-Supervisory Board at PAION AG since 2017, and Member-Supervisory Board at CureVac SE since 2015.
Former positions include Independent Non-Executive Director at Private Equity Holding AG from 2012 to 2018, Director at Hugin AS, Director at Joimax GmbH, Non-Executive Director at Cosmo Pharmaceuticals NV from 2020 to 2021, Independent Non-Executive Director at DKSH Holding Ltd. from 2012 to 2025, CFO, Executive Director & Head-Investor Relations at Cosmo Pharmaceuticals SA from 2010 to 2016, Head-Corporate Finance & Capital Markets at UBS AG from 1992 to 1998, Partner at Ernst Mueller Moehl from 1998 to 2001, Head-Corporate Banking at UBS South Africa (Pty) Ltd. from 1987 to 1992, Chief Financial Officer at Cassiopea SpA from 2015 to 2020, Head-Corporate Banking at UBS Australia Pty Ltd. from 1987 to 1992, and Member-Supervisory Board at CureVac NV from 2015 to 2023.
Postes actifs de Hans Tanner
| Sociétés | Poste | Début |
|---|---|---|
| PAION AG | Directeur/Membre du Conseil | 01/06/2017 |
Lifematrix Technologies AG
 Lifematrix Technologies AG Miscellaneous Commercial ServicesCommercial Services Develops human cell derived and off the shelf available tissue engineered implants | Directeur/Membre du Conseil | - |
Wyss Zurich
 Wyss Zurich Investment ManagersFinance Wyss Zurich is an active manager. | Directeur/Membre du Conseil | - |
FARa Holz AG
 FARa Holz AG Forest ProductsNon-Energy Minerals Engages in timber trading | Directeur/Membre du Conseil | - |
CureVac SE
 CureVac SE BiotechnologyHealth Technology Develops tumor immunotherapies | Directeur/Membre du Conseil | 01/01/2015 |
Cosmo Holding SpA
 Cosmo Holding SpA Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Directeur/Membre du Conseil | 01/01/2005 |
Qvanteq AG
 Qvanteq AG BiotechnologyHealth Technology Develops novel bioactive stents | Directeur/Membre du Conseil | 01/01/2010 |
Cosmo Bioscience, Inc.
 Cosmo Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Cosmo Bioscience SpA, Cosmo Bioscience, Inc. is a distributor of life science research products and reagents, primarily sourced from Japanese and international manufacturers. The company is based in San Diego, CA. The company offers a catalog that includes antibodies, assays, ELISA kits, biomolecules, cells and cell separation products, consumables, instruments, media and supplements, molecular biology tools, proteins, standards, and specialized items such as MHC tetramers and cell-free protein synthesis systems. Cosmo Bioscience supports research in areas such as immunology, oncology, neurodegeneration, bone biology, extracellular matrix biology, extracellular vesicles, metabolism, reproductive biology, food science and safety, and stem cell biology. The company provides reagents optimized for techniques including immunohistochemistry, western blotting, flow cytometry, immunofluorescence, and functional assays, as well as proprietary and partner products like the Cosmo antibody collection, MHC tetramers, PureFrex cell-free protein synthesis system, and specialized IVF and transgenic research reagents. Custom services include tailored MHC monomer and tetramer production, multiplex IHC kits, and custom protein expression solutions. | Directeur/Membre du Conseil | 28/04/2010 |
Anciens postes connus de Hans Tanner
| Sociétés | Poste | Fin |
|---|---|---|
| DKSH HOLDING AG | Directeur/Membre du Conseil | 27/03/2025 |
| ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Hans Tanner
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
53
Relations au 1er degré
24
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 24 |
|---|---|
UBS AG
 UBS AG Investment ManagersFinance Provides financial advice and wealth management services | Finance |
Private Equity Holding AG
 Private Equity Holding AG Investment ManagersFinance Acts as Private Equity Fund | Finance |
PAION AG
 PAION AG Pharmaceuticals: MajorHealth Technology Operates as a holding company whose subsidiaries develops and commercializes specialty pharmaceutical products | Health Technology |
Cosmo Pharmaceuticals SA
 Cosmo Pharmaceuticals SA Pharmaceuticals: MajorHealth Technology Operates as a specialty pharmaceutical company | Health Technology |
CureVac SE
CureVac SE BiotechnologyHealth Technology Develops tumor immunotherapies | Health Technology |
20 Minuten-Holding AG
 20 Minuten-Holding AG Publishing: NewspapersConsumer Services Holding group with interests in publishing | Consumer Services |
Ernst Mueller Moehl
 Ernst Mueller Moehl Investment Banks/BrokersFinance Provides investment services | Finance |
A&A Active Investor AG
 A&A Active Investor AG Investment Banks/BrokersFinance Investment company focusing on long-term value creation through active ownership in listed companies. | Finance |
20 Minuten AG
 20 Minuten AG Publishing: NewspapersConsumer Services Provides online news publishing services | Consumer Services |
University of St. Gallen
 University of St. Gallen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DKSH Holding Ltd.
 DKSH Holding Ltd. Medical DistributorsDistribution Services Operates as a holding company which engages in the consumer goods, healthcare, performance materials and technology activities | Distribution Services |
Hugin AS
 Hugin AS Internet Software/ServicesTechnology Services Provides communication and distribution services for listed European companies | Technology Services |
UBS South Africa (Pty) Ltd.
 UBS South Africa (Pty) Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Cassiopea SpA
 Cassiopea SpA Pharmaceuticals: MajorHealth Technology Manufactures dermatological drugs | Health Technology |
Cosmo Holding SpA
Cosmo Holding SpA Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Cosmo Bioscience, Inc.
Cosmo Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Cosmo Bioscience SpA, Cosmo Bioscience, Inc. is a distributor of life science research products and reagents, primarily sourced from Japanese and international manufacturers. The company is based in San Diego, CA. The company offers a catalog that includes antibodies, assays, ELISA kits, biomolecules, cells and cell separation products, consumables, instruments, media and supplements, molecular biology tools, proteins, standards, and specialized items such as MHC tetramers and cell-free protein synthesis systems. Cosmo Bioscience supports research in areas such as immunology, oncology, neurodegeneration, bone biology, extracellular matrix biology, extracellular vesicles, metabolism, reproductive biology, food science and safety, and stem cell biology. The company provides reagents optimized for techniques including immunohistochemistry, western blotting, flow cytometry, immunofluorescence, and functional assays, as well as proprietary and partner products like the Cosmo antibody collection, MHC tetramers, PureFrex cell-free protein synthesis system, and specialized IVF and transgenic research reagents. Custom services include tailored MHC monomer and tetramer production, multiplex IHC kits, and custom protein expression solutions. | Commercial Services |
Joimax GmbH
 Joimax GmbH Medical SpecialtiesHealth Technology Develops and markets systems for endoscopic minimally invasive spinal surgery | Health Technology |
UBS Australia Pty Ltd.
 UBS Australia Pty Ltd. Investment ManagersFinance Provides wealth management, asset management and investment banking services | Finance |
Qvanteq AG
Qvanteq AG BiotechnologyHealth Technology Develops novel bioactive stents | Health Technology |
Cosmo Pharmaceuticals NV
 Cosmo Pharmaceuticals NV Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for gastrointestinal diseases and dermatology | Health Technology |
FARa Holz AG
FARa Holz AG Forest ProductsNon-Energy Minerals Engages in timber trading | Non-Energy Minerals |
Wyss Zurich
Wyss Zurich Investment ManagersFinance Wyss Zurich is an active manager. | Finance |
CureVac NV
 CureVac NV BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops medicines based on messenger ribonucleic acid which includes prophylactic vaccines, oncology, and molecular therapies | Health Technology |
Lifematrix Technologies AG
Lifematrix Technologies AG Miscellaneous Commercial ServicesCommercial Services Develops human cell derived and off the shelf available tissue engineered implants | Commercial Services |
